门脉高压导致难治性腹水介入治疗的临床价值分析

Analysis of Interventional Therapies on Refractory Ascites Due to Portal Hypertension

目的分析门脉高压导致难治性腹水介入治疗的临床价值。方法收集16例门脉高压导致难治性腹水进行了介入治疗的患者,对介入治疗后的腹水缓解率、手术并发症发生率、半年腹水复发率、半年支架再狭窄率等进行分析。结果介入手术对门脉高压导致难治性腹水的腹水缓解率是100%(16/16);手术并发症发生率为6.25%(1/16),发生并发症的1例为腹腔出血;腹水复发率为0%(0/16);支架再狭窄率12.50%(2/16)。结论介入治疗,包括血管成形术、TIPS、第二肝门重建等方法可有效地减少门脉高压导致难治性腹水,短期效果明显,腹水再发率低,是高效、安全的方法。

Objective To analyze the clinical value of interventional therapies on refractory ascites due to portal hypertension. Methods 16 patients with refractory ascites due to portal hypertension were selected as research objects. The clinical data were investigated. Results The rate for interventional treatment in alleviating refractory ascites due to portal hypertension was 1 00% （16/16）. Operation related complications in terms of abdominal bleeding occurred in 6.25% （1/16）. No recurrence of ascites occurred within the following six months, while the stent stenosis presented in 12.50% （2/16） patients. Conclusions lnterventional therapies, including angioplasty, TIPS, secondary porta reconstruction are highly effective and safe methods in reducing refractory ascites which result from portal hypertension, with a high efficiency and low recurrence in short-term.